FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Friday, June 14, 2024 04:11 PM
Though the US Food and Drug Administration (FDA) last week recommended that vaccine companies switch to the JN.1 variant for updated shots for the fall, yesterday it urged companies to focus on the KP.2 lineage if possible, based on recent shifts and a national rise in cases. Read more.